BlackRock’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132K | Sell |
|
|||||
|
2025
Q1 | $126K | Sell |
|
|||||
|
2024
Q4 | $171K | Sell |
|
|||||
|
2024
Q3 | $401K | Sell |
|
|||||
|
2024
Q2 | $1.08M | Sell |
|
|||||
|
2024
Q1 | $3.94M | Sell |
|
|||||
|
2023
Q4 | $5.47M | Buy |
|
|||||
|
2023
Q3 | $7.42M | Sell |
|
|||||
|
2023
Q2 | $15.6M | Buy |
|
|||||
|
2023
Q1 | $408K | Sell |
|
|||||
|
2022
Q4 | $1.61M | Sell |
|
|||||
|
2022
Q3 | $1.79M | Buy |
|
|||||
|
2022
Q2 | $3.31M | Sell |
|
|||||
|
2022
Q1 | $8.07M | Sell |
|
|||||
|
2021
Q4 | $11M | Buy |
|
|||||
|
2021
Q3 | $8.67M | Buy |
|
|||||
|
2021
Q2 | $49.2M | Buy |
|
|||||
|
2021
Q1 | $7.6M | Buy |
|
|||||
|
2020
Q4 | $2.57M | Buy |
|
|||||
|
2020
Q3 | $2.65M | Hold |
|
|||||
|
2020
Q2 | $1.36M | Sell |
|
|||||
|
2020
Q1 | $1.2M | Sell |
|
|||||
|
2019
Q4 | $2.23M | Buy |
|
|||||
|
2019
Q3 | $1.78M | Buy |
|
|||||
|
2019
Q2 | $2.18M | Buy |
|
|||||
|
2019
Q1 | $1.44M | Buy |
|
|||||
|
2018
Q4 | $1.99M | Sell |
|
|||||
|
2018
Q3 | $3.03M | Buy |
|
|||||
|
2018
Q2 | $2.61M | Buy |
|
|||||
|
2018
Q1 | $467K | Sell |
|
|||||
|
2017
Q4 | $361K | Buy |
|
|||||
|
2017
Q3 | $701K | Sell |
|
|||||
|
2017
Q2 | $699K | Buy |
|
|||||
|
2017
Q1 | $979K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $304K | Buy |
|